Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Effects of proteasome inhibitors on cytokines, metalloproteinases and their inhibitors and collagen type-I expression in periprosthetic tissues and fibroblasts from loose arthroplasty endoprostheses.

Niarakis A, Giannopoulou E, Syggelos SA, Panagiotopoulos E.

Connect Tissue Res. 2019 Mar 31:1-16. doi: 10.1080/03008207.2019.1601186. [Epub ahead of print]


Computational Systems Biology Approach for the Study of Rheumatoid Arthritis: From a Molecular Map to a Dynamical Model.

Singh V, Ostaszewski M, Kalliolias GD, Chiocchia G, Olaso R, Petit-Teixeira E, Helikar T, Niarakis A.

Genom Comput Biol. 2018;4(1). pii: e100050. doi: 10.18547/gcb.2018.vol4.iss1.e100050. Epub 2017 Dec 6.


Community-driven roadmap for integrated disease maps.

Ostaszewski M, Gebel S, Kuperstein I, Mazein A, Zinovyev A, Dogrusoz U, Hasenauer J, Fleming RMT, Le Novère N, Gawron P, Ligon T, Niarakis A, Nickerson D, Weindl D, Balling R, Barillot E, Auffray C, Schneider R.

Brief Bioinform. 2019 Mar 25;20(2):659-670. doi: 10.1093/bib/bby024.


Computational modeling of the main signaling pathways involved in mast cell activation.

Niarakis A, Bounab Y, Grieco L, Roncagalli R, Hesse AM, Garin J, Malissen B, Daëron M, Thieffry D.

Curr Top Microbiol Immunol. 2014;382:69-93. doi: 10.1007/978-3-319-07911-0_4. Review.


Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprostheses.

Niarakis A, Giannopoulou E, Ravazoula P, Panagiotopoulos E, Zarkadis IK, Aletras AJ.

FEBS J. 2013 Dec;280(24):6541-55. doi: 10.1111/febs.12555. Epub 2013 Oct 25.


Proteomic analysis of the SH2 domain-containing leukocyte protein of 76 kDa (SLP76) interactome in resting and activated primary mast cells [corrected].

Bounab Y, Hesse AM, Iannascoli B, Grieco L, Couté Y, Niarakis A, Roncagalli R, Lie E, Lam KP, Demangel C, Thieffry D, Garin J, Malissen B, Daëron M.

Mol Cell Proteomics. 2013 Oct;12(10):2874-89. doi: 10.1074/mcp.M112.025908. Epub 2013 Jul 2. Erratum in: Mol Cell Proteomics. 2013 Feb ;13(2):678.


Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.

Taylor M, Moore S, Mourtas S, Niarakis A, Re F, Zona C, La Ferla B, Nicotra F, Masserini M, Antimisiaris SG, Gregori M, Allsop D.

Nanomedicine. 2011 Oct;7(5):541-50. doi: 10.1016/j.nano.2011.06.015. Epub 2011 Jun 29.


Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide.

Mourtas S, Canovi M, Zona C, Aurilia D, Niarakis A, La Ferla B, Salmona M, Nicotra F, Gobbi M, Antimisiaris SG.

Biomaterials. 2011 Feb;32(6):1635-45. doi: 10.1016/j.biomaterials.2010.10.027. Epub 2010 Dec 4.


Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.

Markoutsa E, Pampalakis G, Niarakis A, Romero IA, Weksler B, Couraud PO, Antimisiaris SG.

Eur J Pharm Biopharm. 2011 Feb;77(2):265-74. doi: 10.1016/j.ejpb.2010.11.015. Epub 2010 Nov 29.


Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9.

Pavlaki M, Giannopoulou E, Niarakis A, Ravazoula P, Aletras AJ.

Mol Cell Biochem. 2009 Aug;328(1-2):189-99. doi: 10.1007/s11010-009-0089-2. Epub 2009 Mar 29.


Antiovarian antibodies in primary Sjogren's syndrome.

Euthymiopoulou K, Aletras AJ, Ravazoula P, Niarakis A, Daoussis D, Antonopoulos I, Liossis SN, Andonopoulos AP.

Rheumatol Int. 2007 Oct;27(12):1149-55. Epub 2007 May 31.


Supplemental Content

Loading ...
Support Center